|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61L 27/52 | (2006.01) |
| A61Q 19/08 | (2013.01) | ||
| A61K 8/735 | (2013.01) | ||
| A61K 8/042 | (2013.01) | ||
| A61K 8/24 | (2013.01) | ||
| A61K2800/80 | (2013.01) | ||
| A61L 27/52 | (2013.01) | ||
| A61L2400/06 | (2013.01) | ||
| A61L2430/34 | (2013.01) | ||
| A61L2430/40 | (2013.01) | ||
| A61L 27/46 | (2013.01) |
| (11) | Patento numeris | 3509559 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 17848293.1 |
| Europos patento paraiškos padavimo data | 2017-09-07 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-07-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-06-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IL2017/051019 |
| Data | 2017-09-07 |
| (87) | Numeris | WO 2018/047182 |
| Data | 2018-03-15 |
| (30) | Numeris | Data | Šalis |
| 201662384219 P | 2016-09-07 | US |
| (72) |
SEGAL, David Dadi , IL
GOLDBERG, Eran , IL
SHKLANOVSKY, Lital , IL
ZINGER, Ariel , IL
GOLDSHAID-ZMIRI, Liat , IL
|
| (73) |
Allergan Pharmaceuticals International Limited ,
Clonshaugh Business & Technology Park, Dublin 17, D17 E400,
IE
|
| (54) | METHODS OF MANUFACTURING INJECTABLE GELS COMPRISING CROSS-LINKED HYALURONIC ACID AND HYDROXYAPATITE |
| METHODS OF MANUFACTURING INJECTABLE GELS COMPRISING CROSS-LINKED HYALURONIC ACID AND HYDROXYAPATITE |